VENUSMEDTECH
LIVE

Serial Number

79209714

Owner

Venus Medtech (Hangzhou) Inc.

Attorney

Victoria Friedman

Filing Date

Mar 16, 2017

Add to watchlist:

No watchlists yet
View on USPTO

VENUSMEDTECH Trademark

Serial Number: 79209714 • Registration: 5304056

VENUSMEDTECH is a trademark filed by Venus Medtech (Hangzhou) Inc. on March 16, 2017. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Venus Medtech (Hangzhou) Inc. (20 trademarks)

Room 311, Floor 3, Building 2,

Entity Type: 99

Trademark Details

Filing Date

March 16, 2017

Registration Date

October 10, 2017

Published for Opposition

July 25, 2017

Goods & Services

Medical apparatus and instruments, namely, artificial heart valves and heart valve; delivery catheters; catheters; surgical implants comprised of artificial materials; medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 22, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Feb 22, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 13, 2024 APRE
TEAS SECTION 71 RECEIVED
Jun 12, 2023 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Aug 26, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 12, 2021 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 23, 2018 ADCH
NOTIFICATION PROCESSED BY IB
Dec 15, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Nov 29, 2017 FICS
FINAL DISPOSITION PROCESSED
Nov 29, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 9, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 10, 2017 R.PR
PUBLISHED FOR OPPOSITION
Jul 25, 2017 PUBO
NOTICE OF PUBLICATION
Jul 5, 2017 NPUB
APPLICATION FILING RECEIPT MAILED
Jun 17, 2017 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 14, 2017 CNSA
ASSIGNED TO EXAMINER
Jun 13, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 13, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 10, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 8, 2017 REPR